Botox (onabotulinumtoxinA, AbbVie/Allergan Aesthetics) and Dysport (abobotulinumtoxinA, Galderma) are both FDA-cleared neuromodulators, but they differ in molecular weight, diffusion radius, onset kinetics, and unit-to-unit potency—differences that affect clinical outcomes, patient expectations, and your supply costs.

Molecular Structure and Diffusion